DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 3AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
02 1LOTREL
03 2ZONISAMIDE
Reset all filters
01 120364
02 177183
03 177215
04 177644
05 177869
06 178381
Reset all filters
01 6No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77183
Country : US
Patented : No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77215
Country : US
Patented : No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 78381
Country : US
Patented : No
Drug : ZONISAMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77869
Country : US
Patented : No
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Drug : LOTREL
Dosage Form : CAPSULE; ORAL
Application Number : 20364
Country : US
Patented : No
Drug : ZONISAMIDE
Dosage Form : CAPSULE; ORAL
Application Number : 77644
Country : US
Patented : No